Intra-lysosomal peptide assembly for the high

A research team, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has developed a groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance.

Related Keywords

South Korea ,United States ,American ,Korea ,Batakrishna Jana ,Seongeon Jin ,Ja Hyoung Ryu ,Department Of Chemical ,Research Professor Batakrishna Jana Department Of Chemistry ,Seongeon Jin Korea Institute Of Science ,Journal Of The American Chemical Society ,Ministry Of Science ,National Research Foundation Of Korea ,Engineering At Korea University ,Department Of Chemistry ,Technology Development Program ,Professor Ja Hyoung Ryu ,Research Professor Batakrishna Jana ,Korea Institute ,Sang Kyu Kwak ,Biological Engineering ,Korea University ,Mid Career Researcher Project ,Medical Technology Development Program ,National Research Foundation ,American Chemical Society ,Intra Lysosomal Peptide Assembly ,High Selectivity Index ,Lysosomal Peptide Assembly ,